-
公开(公告)号:US20090326832A1
公开(公告)日:2009-12-31
申请号:US12163774
申请日:2008-06-27
申请人: David E. Heckerman , Carl M. Kadie , Hyunmin Kang
发明人: David E. Heckerman , Carl M. Kadie , Hyunmin Kang
CPC分类号: G16B20/00
摘要: Systems and methods are provided for the identification of genotype-phenotype associations in genome-wide association (GWA) studies. In an illustrative implementation, a data correlation environment comprises a population structure engine and at least one instruction set to instruct the population structure engine to process pedigree or population genetic data to generate a population structure sub-model according to a selected graphical model-based data correlation paradigm. Illustratively, the parameter of the resulting generalized linear mixed model can be learned using a variational approximation.
摘要翻译: 提供系统和方法用于鉴定全基因组关联(GWA)研究中的基因型 - 表型关联。 在说明性实现中,数据相关环境包括总体结构引擎和至少一个指令集,以指示人口结构引擎处理血统或群体遗传数据,以根据所选择的基于图形模型的数据生成群体结构子模型 相关范式 说明性地,可以使用变分近似来学习所得到的广义线性混合模型的参数。
-
公开(公告)号:US5650399A
公开(公告)日:1997-07-22
申请号:US420326
申请日:1995-04-11
申请人: Steven E. Rokita , Hyunmin Kang
发明人: Steven E. Rokita , Hyunmin Kang
CPC分类号: C07H21/00
摘要: Anthraquinone derivatives are constructed for alkylation of target molecules. The anthraquinone derivative includes an anthraquinone ring system which has been modified by the addition of inducibly reactive substituents at positions on the ring system. The anthraquinone ring system can be selectively activated for alkylation of a target molecule. The substituents may be from 1 to 4 methyl groups, whereupon activation is achieved by a photochemical signal. In an additional alternative embodiment, the inducible reactive substituents may include both methyl groups and substituted methylene groups. In this embodiment, the activation of the anthraquinone derivative is achieved by photochemical and/or reductive signals. Alternatively, the substituents may be from 1 to 8 methyl groups modified to include a reactive group, whereupon activation is achieved by a chemical or enzymatic reductive signal. The anthraquinone derivatives of the invention may be used for non-specific modification of target molecules. Alternatively, the anthraquinone derivative may be further derivatized to permit specific modification of target molecules. The further derivatization of the anthraquinone includes attaching a probe to the anthraquinone ring system by way of a linking group. The probe is chosen to selectively localize to a target molecule, whereupon the anthraquinone derivative may be activated to react with and aklylate the target molecule. Also the process of employing such anthraquinone derivatives for use in vitro or in vivo for alkylating, specifically or non-specifically alkylating, target molecules.
摘要翻译: 构建蒽醌衍生物用于靶分子的烷基化。 蒽醌衍生物包括通过在环系上的位置添加可诱导的反应性取代基而被修饰的蒽醌环体系。 可以选择性地活化蒽醌环体系用于靶分子的烷基化。 取代基可以是1至4个甲基,因此通过光化学信号实现活化。 在另外的替代实施方案中,可诱导的反应性取代基可以包括甲基和取代的亚甲基。 在该实施方案中,通过光化学和/或还原信号实现蒽醌衍生物的活化。 或者,取代基可以是经修饰以包括反应性基团的1至8个甲基,因此通过化学或酶还原信号实现活化。 本发明的蒽醌衍生物可用于靶分子的非特异性修饰。 或者,可以将蒽醌衍生物进一步衍生化,以允许目标分子的特异性修饰。 蒽醌的进一步衍生化包括通过连接基团将探针附着到蒽醌环体系上。 选择该探针以选择性地定位于靶分子,于是该蒽醌衍生物可以被活化以与靶分子反应并使其成为碱基。 也是使用这种蒽醌衍生物在体外或体内用于烷基化,特异性或非特异性烷基化靶分子的方法。
-
公开(公告)号:US20100280098A1
公开(公告)日:2010-11-04
申请号:US12681260
申请日:2008-10-06
申请人: Rudolph L. Juliano , Rowshon Alam , Vidula Dixit , Hyunmin Kang , Xiaoyuan Chen , Zi-Bo Li
发明人: Rudolph L. Juliano , Rowshon Alam , Vidula Dixit , Hyunmin Kang , Xiaoyuan Chen , Zi-Bo Li
IPC分类号: A61K31/7105 , C12N5/071 , A61P43/00
CPC分类号: A61K31/70 , C12N15/111 , C12N2310/11 , C12N2310/14 , C12N2310/315 , C12N2310/321 , C12N2310/3513 , C12N2310/3517 , C12N2320/32 , C12N2310/3521
摘要: Disclosed herein are oligonucleotide conjugates that include ligands that target cell receptors that mediate endocytosis. The ligands can include peptides and small molecules. The conjugates can include carrier macromolecules to which the ligands and oligonucleotides are attached, or conjugates where an oligonucleotide is attached to a ligand in the absence of a carrier macromolecule. The oligonucleotides can include therapeutic oligonucleotides, such as siRNA, antisense RNA and miRNA. The ligand can be an RGD peptide. Also disclosed herein are methods of delivering the conjugates to cells in subjects.
摘要翻译: 本文公开了包含靶向调解内吞的细胞受体的配体的寡核苷酸缀合物。 配体可以包括肽和小分子。 缀合物可以包括配体和寡核苷酸所连接的载体大分子,或者在不存在载体大分子时寡核苷酸与配体连接的结合物。 寡核苷酸可以包括治疗性寡核苷酸,例如siRNA,反义RNA和miRNA。 配体可以是RGD肽。 本文还公开了将缀合物递送至受试者中的细胞的方法。
-
公开(公告)号:US20080199960A1
公开(公告)日:2008-08-21
申请号:US11596238
申请日:2005-05-13
申请人: Rudolph L. Juliano , Hyunmin Kang , Anna Astriab-Fisher , Piet Herdewijn , Patrick Chaltin , Arthur Van Aerschot
发明人: Rudolph L. Juliano , Hyunmin Kang , Anna Astriab-Fisher , Piet Herdewijn , Patrick Chaltin , Arthur Van Aerschot
CPC分类号: C12N15/1138 , C07H21/04 , C12N15/111 , C12N2310/11 , C12N2310/14 , C12N2310/321 , C12N2310/322 , C12N2310/3231 , C12N2310/341 , C12N2310/3513 , C12N2310/3515 , C12N2310/53 , C12N2320/32 , C12N2320/51 , C12N2310/3521 , C12N2310/3525 , C12N2310/3527
摘要: The presently disclosed subject matter relates to the delivery of oligonucleotides to cells through the delivery of a composition or reagent comprising a hybridization complex comprising a first antisense oligonucleotide which is modified to have a higher stability against degradation, and a second sense oligonucleotide which is prone to degradation. The presently disclosed subject matter furthermore relates to dendrimeric bioconjugates and compositions or reagents comprising them, wherein the bioconjugate comprises a conjugate moiety coupled to a dendrimeric structure and to their use to deliver oligomeric compounds including oligonucleotides or duplexes, as described above, to cells for modulation of gene expression (i.e. antisense or antigene therapy/research, RNA interference).
摘要翻译: 目前公开的主题涉及通过递送包含杂交复合物的组合物或试剂递送寡核苷酸,所述杂交复合物包含经修饰以具有较高抗降解稳定性的第一反义寡核苷酸,以及易于 降解。 目前公开的主题还涉及含有它们的树枝状聚合生物共轭物和组合物或试剂,其中生物缀合物包含与树枝状大分子结构偶联的缀合物部分,以及它们用于将如上所述的寡核苷酸或双链体的寡聚化合物递送至用于调制的细胞 的基因表达(即反义或反向治疗/研究,RNA干扰)。
-
-
-